Home
Webtool
Database
Overview
Perturbagen
Expression Profiles
Transcriptional Responses
Download
Documentation
Contact
Home
Panel
Database
Overview
Perturbagen
Expression Profiles
Transcriptional Responses
Download
Documentation
Contact
Home
Webtool
Database
Overview
Perturbagen
Expression Profiles
Transcriptional Responses
Download
Documentation
Contact
Targets of perturbagens
Perturbagen ID : CID57441
Perturbagen : (2r,3z,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (z)-(2r,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; Acide clavulanique; Acidum clavulanicum; Amoxi-clav; Amoxicillan and clavulanate potassium; Amoxicillin and clavulanate potassium; Amoxicillin/clavulanate potassium; Antibiotic mm 14151; Apo-amoxi clav; Apo-amoxi clav 250/125; Apo-amoxi clav 500/125; Apo-amoxi clav 875/125; Augmentin; Augmentin es-600; Augmentin xr; Augmentinxr; Clavulanic acid; Clavulansäure; Clavulin 125 f oral sus; Clavulin 200; Clavulin 250 f oral sus; Clavulin 250 tab; Clavulin 400; Clavulin 500 f tab; Clavulin 875; Mm 14151; Novo-clavamoxin 125; Novo-clavamoxin 250; Novo-clavamoxin 875; Pms-amclav-200; Pms-amclav-400; Pms-amclav-875; Ratio-aclavulanate; Ratio-aclavulanate 125 f; Ratio-aclavulanate 250 f; Timentin; Ácido clavulánico
Target
Effect
Reference
blaZ
-1
DrugBank
pbpA
-1
DrugBank
mecA
-1
DrugBank